News

image

Tricked-Out Immune Cells Could Attack Cancer, Spare Healthy Cells

January 28, 2016

UC San Francisco scientists have created a new class of highly customizable biological sensors that can be used to form “logic gates” inside cells of the immune system, giving these cells the capability to home in on and kill a wide range of cancer cells while preventing them from attacking normal tissue.

For Breast Cancer Patients, Never Too Late To Quit Smoking

For Breast Cancer Patients, Never Too Late To Quit Smoking

January 27, 2016

Documenting that it’s never too late to quit smoking, a large study of breast cancer survivors has found that those who quit smoking after their diagnosis had a 33 percent lower risk of death as a result of breast cancer than those who continued to smoke.

HDFCCC Joins Nation’s Cancer Centers in Endorsement of HPV Vaccination for Cancer Prevention

HDFCCC Joins Nation’s Cancer Centers in Endorsement of HPV Vaccination for Cancer Prevention

January 27, 2016

In response to low national vaccination rates for the human papillomavirus (HPV), the UCSF Helen Diller Family Comprehensive Cancer Center has joined the other 68 NCI-designated cancer centers in issuing a statement urging for increased HPV vaccination for the prevention of cancer.

Are We Ready for a Blood Test for Cancer?

Are We Ready for a Blood Test for Cancer?

January 22, 2016

What if screening for cancer was as easy as checking your cholesterol? That’s the promise of techniques currently in development that may one day make it possible to detect the earliest stages of cancer with an annual blood draw.
 
E-cigarettes, as Used, Aren’t Helping Smokers Quit, Study Shows

E-cigarettes, as Used, Aren’t Helping Smokers Quit, Study Shows

January 15, 2016

Electronic cigarettes are widely promoted and used to help smokers quit traditional cigarettes, but a new analysis from UC San Francisco found that adult smokers who use e-cigarettes are actually 28 percent less likely to stop smoking cigarettes.

NCCN Awards Research Grants to Five Investigators to Study Effectiveness of Enzalutamide in Various Cancers

NCCN Awards Research Grants to Five Investigators to Study Effectiveness of Enzalutamide in Various Cancers

January 13, 2016

The NCCN Oncology Research Program has awarded five research grants to investigate the effectiveness of enzalutamide in mantle cell lymphoma and endometrial, hepatocellular, and prostate cancers.